Invesco Ltd.

Position in FTRE — Fortrea Holdings Inc.

CIK 914208 Atlanta, GA

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$12,763,333

+$5,984,967 QoQ

Shares Held

733,525

+1.9% QoQ

Ownership

0.771%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#30

of 334 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 95% None 5%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. FTRE ranks #52 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,763,333	733,525	+1.9%	Shares	Defined	2026-08-14
2026-03-31	$6,778,366	719,572	-9.4%	Shares	Defined	2026-05-12
2025-12-31	$13,707,107	794,615	+9.0%	Shares	Defined	2026-02-19
2025-09-30	$6,136,730	728,828	-18.8%	Shares	Defined	2025-11-13
2025-06-30	$4,434,911	897,756	+26.5%	Shares	Defined	2025-08-13
2025-03-31	$5,356,706	709,498	+29.9%	Shares	Defined	2025-05-12
2024-12-31	$10,185,882	546,160	+20.5%	Shares	Defined	2025-02-13
2024-09-30	$9,067,720	453,386	-33.5%	Shares	Defined	2024-11-12
2024-06-30	$15,907,001	681,534	+66.3%	Shares	Defined	2024-08-13
2024-03-31	$16,455,029	409,941	-25.3%	Shares	Defined	2024-05-14
2023-12-31	$19,161,040	549,027	+0.4%	Shares	Defined	2024-02-13
2023-09-30	$15,631,777	546,757	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.